Atrial pressure, atrial natriuretic factor (ANF), the renin-angiotensin-aldosterone system, and renal hemodynamic functions were examined during and after right ventricular pacing in anesthetized dogs (n=9). Mean arterial pressure, cardiac output, and renal blood flow decreased during tachycardia while right and left atrial pressures increased. ANF markedly increased during tachycardia but urinary and fractional excretion of sodium were unchanged from control. Plasma renin activity was not increased during pacing despite the decrease in renal perfusion pressure. After tachycardia and restoration of mean arterial pressure to control, ANF declined but remained elevated above control despite a return of atrial pressure to control level. After tachycardia, urinary and fractional sodium excretion increased significantly in the absence of an increase in glomerular filtration rate. These findings support the following conclusions: 1) tachycardia increases ANF in association with increased atrial pressure; however, an elevation ofANF persists following tachycardia despite the absence of the persistent stimulus of elevated atrial pressures; 2) the increase in ANF during tachycardia may contribute to the absence of a decrease in sodium excretion and activation of the reninangiotensin system that occurs with reduction in renal perfusion pressure; and 3) tachycardiainduced natriuresis may be dependent on an increase in ANF and the maintenance of renal perfusion pressure. (Circulation Research 1990;66:76- trations of ANF and consequent changes in sodium excretion and plasma renin activity. Rapid right ventricular pacing in the dog was employed as a model of tachycardia. The specific hypotheses tested were 1) circulating concentrations of ANF parallel changes in atrial pressure during and following tachycardia, 2) sodium excretion parallels circulating concentrations of ANF during and following tachycardia, and 3) an inverse relation exists between plasma ANF concentration and plasma renin activity during and following tachycardia. To test further the relation between elevated ANF upon renin activity during reductions in renal perfusion pressure as observed during tachycardia graded constriction of the suprarenal aorta in the presence and absence of exogenous ANF was also performed in a separate group of dogs.
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Atrial pressure, atrial natriuretic factor (ANF), the renin-angiotensin-aldosterone system, and renal hemodynamic functions were examined during and after right ventricular pacing in anesthetized dogs (n=9). Mean arterial pressure, cardiac output, and renal blood flow decreased during tachycardia while right and left atrial pressures increased. ANF markedly increased during tachycardia but urinary and fractional excretion of sodium were unchanged from control. Plasma renin activity was not increased during pacing despite the decrease in renal perfusion pressure. After tachycardia and restoration of mean arterial pressure to control, ANF declined but remained elevated above control despite a return of atrial pressure to control level. After tachycardia, urinary and fractional sodium excretion increased significantly in the absence of an increase in glomerular filtration rate. These findings support the following conclusions: 1) tachycardia increases ANF in association with increased atrial pressure; however, an elevation ofANF persists following tachycardia despite the absence of the persistent stimulus of elevated atrial pressures; 2) the increase in ANF during tachycardia may contribute to the absence of a decrease in sodium excretion and activation of the reninangiotensin system that occurs with reduction in renal perfusion pressure; and 3) tachycardiainduced natriuresis may be dependent on an increase in ANF and the maintenance of renal perfusion pressure. (Circulation Research 1990;66:76-83) A trial natriuretic factor (ANF) is a potent hormone of cardiac origin that is released in response to an increase in atrial pressure with associated atrial stretch.12 Exogenous administration of ANF at pharmacological concentrations increases sodium excretion and inhibits renin release. 3 Tachydysrhythmias of atrial and ventricular origin have been shown to increase atrial pressures.4-6 Yet, while previous studies have documented increases in ANF during tachycardia,47-9 the integrated cardiorenal and endocrine responses to tachycardia are conflicting. The current study was, therefore, designed to determine the effect of tachycardia and associated cardiac hemodynamic changes on circulating concen-trations of ANF and consequent changes in sodium excretion and plasma renin activity. Rapid right ventricular pacing in the dog was employed as a model of tachycardia. The specific hypotheses tested were 1) circulating concentrations of ANF parallel changes in atrial pressure during and following tachycardia, 2) sodium excretion parallels circulating concentrations of ANF during and following tachycardia, and 3) an inverse relation exists between plasma ANF concentration and plasma renin activity during and following tachycardia. To test further the relation between elevated ANF upon renin activity during reductions in renal perfusion pressure as observed during tachycardia graded constriction of the suprarenal aorta in the presence and absence of exogenous ANF was also performed in a separate group of dogs.
Materials and Methods

Surgical Preparation
Twenty-four mongrel dogs weighing 16-22 kg were studied. The pacing group comprised nine dogs; each of these dogs received one oral dose of lithium carbonate (300 mg) 12-18 hours before the acute study. Suprarenal aortic clamping. Mean renal perfusion pressure was reduced by graded clamping of the aorta proximal to the renal arteries by an adjustable Blalock clamp placed above both the right and left renal arteries. Renal perfusion pressure was reduced to an extent comparable to that observed with right ventricular pacing-approximately 15% below control mean arterial pressure. The experimental protocol was similar to that described above with two 15-minute control clearances followed by three 15-minute clearances during which renal perfusion pressure was reduced by aortic clamping (n =9). At the completion of this 45-minute period, the clamp was removed and all parameters were again monitored during two 15-minute recovery periods, one immediately postconstriction and one 60 minutes postconstriction. In an additional group of six dogs, ANF was infused systemically (10 ng/kg/min i.v.) beginning 1 minute before and continuing through the period of reduced renal perfusion pressure. The dose of exogenous ANF infused was designed to elevate plasma levels within a physiological range and not to exceed the levels we observed with right ventricular pacing. Arterial blood pressure was measured simultaneously at sites proximal and distal to the aortic clamp through catheters advanced retrogradely from the femoral artery. Hemodynamic, renal, and endocrine parameters were measured during each of the clearance periods.
Analytical Procedures
Extracted arterial plasma levels of ANF were measured by a radioimmunoassay procedure previously described.'0 The lower limit of detection was 3 pg/ml plasma. Glomerular filtration rate was determined by the clearance of inulin with plasma and urine inulin concentrations measured by the anthrone method." Plasma and urinary sodium concentrations were quantified using ion-selective electrodes (System E2A, Beckman Instruments, Brea, California). Plasma and urine lithium concentrations, however, were measured by flame-emission spectrophotometry ( In the postpacing period, heart rate (149± 2) remained above control but had returned to control by the recovery period. Mean arterial pressure and cardiac output were significantly decreased from control with pacing (112±4 to 92±4 mm Hg and 3.2± 0.2 to 2.4 ±0.2 1/min, respectively), while right and left atrial pressures were elevated above control. Renal blood flow was reduced from control (171±11 to 144±12 ml/min) during ventricular pacing. Renal vascular resistance, however, was not altered during pacing, but was significantly elevated in the postpacing periods. Mean arterial pressure returned to control level during the immediate postpacing and recovery periods. Cardiac output did not return to control level in the postpacing periods, but was maintained at the lower pacing-induced level for the remainder of the experimental periods. Peripheral vascular resistance was increased by approximately 40% above control by the time of the recovery phase. Endocrine data. Endocrine responses to ventricularpaced tachycardia are shown in Figure 3 and Table 3 . ANF concentrations increased significantly above control (54+5 pg/ml) with pacing (268+8 pg/ml). ANF then declined during the immediate postpacing period, but remained elevated (83+±-10 pg/ml) above control despite the return of atrial pressure to control levels. Control ANF level was restored, however, during the recovery period.
Despite the significant decrease in renal perfusion pressure during tachycardia, plasma renin activity (PRA) was not significantly elevated from control (3.0+0.5 ng/ml/min) with pacing and remained unchanged throughout the protocol. Aldosterone was unchanged from control (6.3 +0.6 ng%) with pacing, but was elevated during the postpacing periods. In contrast, vasopressin decreased from control (6.2+ 0.5 pg/ml) during ventricular pacing and was then elevated above control in the postpacing period. Plasma osmolalities, however, were unchanged with tachycardia or in the recovery period. Norepinephrine plasma concentration (control, 85+± 13 pg/ml) was elevated with ventricular pacing to 166±15 pg/ml, and while the norepinephrine level declined in the postpacing period, the concentration remained significantly above control level (125+± 14 pg/ml).
Renal function data. Renal function responses to ventricular-paced tachycardia are shown in Figure 4 and changed from control level with pacing (21+5 to 16±4 geq/min) above control as well as above the level observed during pacing. Fractional excretion of sodium also was unchanged with pacing, but increased significantly in the postpacing period. After pacing, both urinary and fractional sodium excretion increased in the absence of increases in glomerular filtration rate. Fractional excretion of lithium, which reflects whole kidney proximal tubule sodium delivery, was not significantly altered from control (28±3%) during ventricular pacing or in the postpacing periods. Filtration fraction also did not change from control during pacing or in the postpacing periods. Serum sodium concentration was unchanged from control (144±0.4 meq/l) during and after pacing.
Suprarenal Aortic Constriction
Hemodynamic data. Figure 5 shows the effects of ANF infusion on proximal and distal aortic blood pressure and renal blood flow with clamping of the suprarenal aorta. Renal perfusion pressure as reflected by mean distal aortic blood pressure was uniformly reduced during clamping in both groups with and without ANF infusion). In contrast, proximal aortic pressure was increased during aortic clamping in the absence of ANF infusion. An increase in proximal arterial pressure with aortic clamping, however, was not observed with the simultaneous infusion of ANF; mean proximal arterial pressures remained at control level. Renal blood flow was significantly reduced during aortic clamping in the absence of exogenous ANF but was preserved in the presence of ANF infusion.
Endocrine data. Endogenous ANF levels were elevated with aortic clamping alone and remained elevated, although decreasing, in the recovery periods ( Figure 5 ). Plasma levels of ANF with exogenous infusion and aortic clamping were elevated to approximately two times that observed with aortic clamping alone. The maximum level of 148+±28 pg/ml, however, was below that observed with right ventricular pacing (269+24 pg/ml). In this group, ANF levels returned to control during recovery. PRA The tachycardia produced significant increases in circulating ANF presumably by the increase in atrial pressures and atrial stretch.1 Previous studies in humans have reported that cardiac pacing increases circulating ANF only when atrial pressure is increased. 15, 16 Increased heart rate alone in humans, without increases in atrial pressure, does not appear to be sufficient to stimulate ANF in vivo. 17 Despite the parallel increases in atrial pressures and ANF during pacing, and the prompt return of atrial pressures to control, ANF did not return to control level immediately after tachycardia in the present study. While alterations in ANF clearance cannot be excluded as during tachycardia, the results of this study suggest that the time course of ANF activity persists despite cessation of the stimulus of atrial pressure for ANF release from the atria.
A contribution of atrial stretch and reflexmediated renal and hemodynamic effects of rapid right ventricular pacing and systemic hypotension cannot be excluded by this study. The modulation by ANF of arterial and cardiopulmonary baroreceptor activity would reflect potentially an indirect mechanism whereby ANF could attenuate the sodium retention effects of renal sympathetic nerve stimulation associated with a decrease in mean systemic arterial pressure. In addition, a buffering effect of ANF on renal hemodynamics is suggested by the absence in --JL..a constrictor response to clamping of the aorta. The present study also further extends the previous report of Sheuer et a125 and demonstrates that the inhibition of renin activation with suprarenal aortic clamping is importantly associated with a maintenance of tubular sodium reabsorption. Aldosterone has also been shown to be inhibited by ANF.26-28The finding that aldosterone levels were not significantly changed during pacing could be interpreted as consistent with a suppression of aldosterone secretion mediated by the high ANF level.
Inhibition of vasopressin has been suggested as a mechanism contributing to the diuresis occurring with tachycardia.6,29 ANF has been shown to inhibit vasopressin action on the collecting duct in vitro,30 but an ANF effect to inhibit vasopressin production or release remains controversial. The findings of the current study indicate that vasopressin was decreased during ventricular pacing in association with elevated ANF levels. Vasopressin levels then increased in the postpacing periods. These results suggest that high ANF levels may participate in the inhibition of vasopressin release; however, other mechanisms such as cardiac baroreceptor reflex-mediated decreases in the neurohypophyseal release of vasopressin are known to be activated by elevated atrial pressures and could contribute to the observed reduction in vasopressin with pacing. It is also evident from these data that the decrease in vasopressin during tachycardia was not in itself sufficient to effect a diuretic response.
In summary, the present findings demonstrate the integrated cardiorenal-endocrine response to tachycardia. These studies confirm the hypothesis that circulating concentrations of ANF increase in association with atrial pressure during tachycardia. However, the failure of ANF to normalize following tachycardia despite normalization of atrial pressure suggests atrial peptide release may occur in the absence of sustained increases in atrial pressure. These studies also demonstrate an attenuated natriuresis to ANF during tachycardia and aortic clamping despite a marked increase in circulating concentrations of the atrial peptide. The natriuresis during the posttachycardia and aortic clamping period when arterial pressure was restored suggests that renal perfusion pressure is an important modulator of the renal response to ANF. Lastly, these studies are consistent with the hypothesis that ANF may inhibit the activation of the renin-angiotensin-aldosterone system during tachycardia despite reductions in arterial and renal perfusion pressures.
